ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 84 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 3.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,963,323 | -25.8% | 7,987,396 | 0.0% | 0.79% | -26.5% |
| Q3 2022 | $3,994,000 | +28.8% | 7,987,396 | +50.5% | 1.07% | -9.3% |
| Q2 2022 | $3,101,000 | -17.9% | 5,307,751 | 0.0% | 1.18% | -26.3% |
| Q1 2022 | $3,779,000 | -55.6% | 5,307,751 | -17.7% | 1.61% | -43.1% |
| Q4 2021 | $8,514,000 | -9.3% | 6,449,856 | +58.0% | 2.83% | +3.1% |
| Q3 2021 | $9,388,000 | -47.6% | 4,081,972 | 0.0% | 2.74% | -34.3% |
| Q2 2021 | $17,919,000 | -39.1% | 4,081,972 | +0.7% | 4.17% | -29.2% |
| Q1 2021 | $29,417,000 | +132.3% | 4,051,972 | +38.2% | 5.89% | +65.1% |
| Q4 2020 | $12,663,000 | +5.1% | 2,931,185 | 0.0% | 3.57% | -16.8% |
| Q3 2020 | $12,047,000 | -31.5% | 2,931,185 | 0.0% | 4.29% | -37.5% |
| Q2 2020 | $17,587,000 | -21.2% | 2,931,185 | -1.0% | 6.86% | -86.9% |
| Q1 2020 | $22,306,000 | -45.2% | 2,962,267 | +0.1% | 52.57% | +71.3% |
| Q4 2019 | $40,679,000 | +14.5% | 2,958,492 | -1.1% | 30.68% | -11.3% |
| Q3 2019 | $35,524,000 | – | 2,990,211 | – | 34.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |